IBDEI2HA ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39575,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,39576,0)
 ;;=D63.8^^152^2000^22
 ;;^UTILITY(U,$J,358.3,39576,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39576,1,3,0)
 ;;=3^Anemia in Chronic Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,39576,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,39576,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,39577,0)
 ;;=C22.3^^152^2000^27
 ;;^UTILITY(U,$J,358.3,39577,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39577,1,3,0)
 ;;=3^Angiosarcoma of Liver
 ;;^UTILITY(U,$J,358.3,39577,1,4,0)
 ;;=4^C22.3
 ;;^UTILITY(U,$J,358.3,39577,2)
 ;;=^5000936
 ;;^UTILITY(U,$J,358.3,39578,0)
 ;;=D61.9^^152^2000^28
 ;;^UTILITY(U,$J,358.3,39578,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39578,1,3,0)
 ;;=3^Aplastic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,39578,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,39578,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,39579,0)
 ;;=D56.1^^152^2000^30
 ;;^UTILITY(U,$J,358.3,39579,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39579,1,3,0)
 ;;=3^Beta Thalassemia
 ;;^UTILITY(U,$J,358.3,39579,1,4,0)
 ;;=4^D56.1
 ;;^UTILITY(U,$J,358.3,39579,2)
 ;;=^340495
 ;;^UTILITY(U,$J,358.3,39580,0)
 ;;=C83.79^^152^2000^32
 ;;^UTILITY(U,$J,358.3,39580,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39580,1,3,0)
 ;;=3^Burkitt Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,39580,1,4,0)
 ;;=4^C83.79
 ;;^UTILITY(U,$J,358.3,39580,2)
 ;;=^5001600
 ;;^UTILITY(U,$J,358.3,39581,0)
 ;;=C83.70^^152^2000^33
 ;;^UTILITY(U,$J,358.3,39581,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39581,1,3,0)
 ;;=3^Burkitt Lymphoma,Unspec Site
 ;;^UTILITY(U,$J,358.3,39581,1,4,0)
 ;;=4^C83.70
 ;;^UTILITY(U,$J,358.3,39581,2)
 ;;=^5001591
 ;;^UTILITY(U,$J,358.3,39582,0)
 ;;=D09.0^^152^2000^40
 ;;^UTILITY(U,$J,358.3,39582,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39582,1,3,0)
 ;;=3^Carcinoma in Situ of Bladder
 ;;^UTILITY(U,$J,358.3,39582,1,4,0)
 ;;=4^D09.0
 ;;^UTILITY(U,$J,358.3,39582,2)
 ;;=^267742
 ;;^UTILITY(U,$J,358.3,39583,0)
 ;;=D06.9^^152^2000^41
 ;;^UTILITY(U,$J,358.3,39583,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39583,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix
 ;;^UTILITY(U,$J,358.3,39583,1,4,0)
 ;;=4^D06.9
 ;;^UTILITY(U,$J,358.3,39583,2)
 ;;=^5001941
 ;;^UTILITY(U,$J,358.3,39584,0)
 ;;=D06.0^^152^2000^43
 ;;^UTILITY(U,$J,358.3,39584,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39584,1,3,0)
 ;;=3^Carcinoma in Situ of Endocervix
 ;;^UTILITY(U,$J,358.3,39584,1,4,0)
 ;;=4^D06.0
 ;;^UTILITY(U,$J,358.3,39584,2)
 ;;=^5001938
 ;;^UTILITY(U,$J,358.3,39585,0)
 ;;=D06.1^^152^2000^44
 ;;^UTILITY(U,$J,358.3,39585,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39585,1,3,0)
 ;;=3^Carcinoma in Situ of Exocervix
 ;;^UTILITY(U,$J,358.3,39585,1,4,0)
 ;;=4^D06.1
 ;;^UTILITY(U,$J,358.3,39585,2)
 ;;=^5001939
 ;;^UTILITY(U,$J,358.3,39586,0)
 ;;=D06.7^^152^2000^42
 ;;^UTILITY(U,$J,358.3,39586,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39586,1,3,0)
 ;;=3^Carcinoma in Situ of Cervix,Other Parts
 ;;^UTILITY(U,$J,358.3,39586,1,4,0)
 ;;=4^D06.7
 ;;^UTILITY(U,$J,358.3,39586,2)
 ;;=^5001940
 ;;^UTILITY(U,$J,358.3,39587,0)
 ;;=D04.9^^152^2000^45
 ;;^UTILITY(U,$J,358.3,39587,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39587,1,3,0)
 ;;=3^Carcinoma in Situ of Skin
 ;;^UTILITY(U,$J,358.3,39587,1,4,0)
 ;;=4^D04.9
 ;;^UTILITY(U,$J,358.3,39587,2)
 ;;=^5001925
 ;;^UTILITY(U,$J,358.3,39588,0)
 ;;=C91.11^^152^2000^48
